Back
Relay Therapeutics Stock Price Chart
Take advantage of the biggest IPO in history
Click here to see more
Buy
58
RLAY
Relay Therapeutics
Last Price:
11.01
Seasonality Move:
8.05%
7 Day Trial
ALL ACCESS PASS
$
7
Is Elon Musk right about AI?
Learn all about it here.- The current trend is relatively stagnant and RLAY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Relay Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.48 | Buy |
| 20-day SMA: | 10.63 | Buy |
| 50-day SMA: | 11.55 | Sell |
| 200-day SMA: | 14.67 | Sell |
| 8-day EMA: | 10.58 | Buy |
| 20-day EMA: | 10.76 | Buy |
| 50-day EMA: | 11.3 | Sell |
| 200-day EMA: | 14.5 | Sell |
Relay Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 51.44 | Buy |
| Chaikin Money Flow: | 1399157 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.27 - 11.39) | Buy |
| Bollinger Bands (100): | (10.25 - 13.11) | Sell |
Relay Therapeutics Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relay Therapeutics Stock
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 11.03 while RLAY 8-day simple moving average is 10.48, which is a Buy signal.
- The stock price of RLAY is 11.03 while Relay Therapeutics 20-day SMA is 10.63, which makes it a Buy.
- Relay Therapeutics 50-day simple moving average is 11.55 while RLAY share price is 11.03, making it a Sell technically.
- RLAY stock price is 11.03 and Relay Therapeutics 200-day simple moving average is 14.67, creating a Sell signal.
RLAY Technical Analysis vs Fundamental Analysis
Buy
58
Relay Therapeutics (RLAY)
is a Buy
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Buy
The current Relay Therapeutics [RLAY] share price is $11.03. The Score for RLAY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Relay Therapeutics Stock Info
Market Cap:
1.35B
Price in USD:
11.03
Share Volume:
1.52M
Relay Therapeutics 52-Week Range
52-Week High:
33.06
52-Week Low:
9.67
Buy
58
Relay Therapeutics (RLAY)
is a Buy
Relay Therapeutics Share Price Forecast
-
What is the Relay Therapeutics stock price today?
The Relay Therapeutics stock price is 11.03 USD today. -
Will RLAY stock go up or go down?
Relay Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relay Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics is not overvalued.
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 11.03 while RLAY 8-day exponential moving average is 10.58, which is a Buy signal.
- The stock price of RLAY is 11.03 while Relay Therapeutics 20-day EMA is 10.76, which makes it a Buy.
- Relay Therapeutics 50-day exponential moving average is 11.30 while RLAY share price is 11.03, making it a Sell technically.
- RLAY stock price is 11.03 and Relay Therapeutics 200-day simple moving average is 14.50, creating a Sell signal.
Fundamental Analysis of Relay Therapeutics
Is Relay Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Relay Therapeutics
Should I short Relay Therapeutics stock?
- RLAY Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Relay Therapeutics is a Sell
- Relay Therapeutics Relative Strength Index (RSI) is 51.44, which suggest Relay Therapeutics is overbought
- The Bollinger Bands (25) for Relay Therapeutics is (10.27 - 11.39), which suggest Relay Therapeutics is a Sell
- The Bollinger Bands (100) for Relay Therapeutics is (10.25 - 13.11), which suggest Relay Therapeutics is a Sell
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.